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Abstract 
Objectives 
We assessed variations in cancer incidence between Latin-speaking countries and between areas 
within those countries. We analysed data from 103 cancer registries (CRs) affiliated to the Group 
for Cancer Epidemiology and Registration in Latin Language Countries (GRELL), published in Cancer 
Incidence in Five Continents, vol. XI (2008-2012) and covering 110 million persons. Our aim was to 
uncover areas of particularly high or low cancer incidence that can be subsequently investigated to 
identify factors responsible for incidence highs and lows. 
Methods 
Age-standardized incidence rates (based on world population) were estimated for all cancers 
combined by sex. CRs were grouped by geographic area according to the coefficient of variation of 
incidence proposed by Crocetti et al. (Eur J Cancer Prev 2017). 
Results 
Over the period 2008-2012 there were 1,151,221 and 978,472 incident cancer cases in males and 
females, respectively, in the 103 CRs. Countries with highest within-country variations in incidence 
were Ecuador, Brazil, Colombia, and Italy for males; and Brazil, Ecuador, France (with overseas 
territories) and Italy for females. For males, areas with lowest rates were Manabi and the Pacific 
area in Ecuador, and Northern Colombia (89.1; 109.4; 139.3); highest rates were in the Azores 
(Portugal), Florianopolis (Brazil), and metropolitan France (382; 380.7; 372.5). For females lowest 
rates were in Manabi and the Pacific area (Ecuador), and Southern Argentina (102; 137.8; 149); 
while highest rates were in Florianopolis, Belgium and Northeast Italy (325.3; 287.4; 274.9). We also 
identified variations in the distribution of cancer types diagnosed by area, both for males and 
females. 
Conclusions 
Our study has revealed major variations in all-cancer incidence between continents, countries and 
regions within countries. These data will be a starting point for further studies on specific cancers 
that aim to identify reasons for cancer incidence highs and lows. 
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